Kistler-Tiffany Companies’s Merck MRK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | $6.1M | Sell |
52,875
-163
| -0.3% | -$18.5K | 0.99% | 17 |
|
|
2023
Q1 | $5.64M | Buy |
53,038
+1,996
| +4% | +$216K | 1.07% | 16 |
|
|
2022
Q4 | $5.66M | Buy |
51,042
+952
| +2% | +$97.3K | 1.16% | 15 |
|
|
2022
Q3 | $4.31M | Sell |
50,090
-154
| -0.3% | -$13.7K | 0.98% | 20 |
|
|
2022
Q2 | $4.58M | Buy |
50,244
+58
| +0.1% | +$5.14K | 1% | 21 |
|
|
2022
Q1 | $4.12M | Sell |
50,186
-1,522
| -3% | -$120K | 0.78% | 27 |
|
|
2021
Q4 | $3.96M | Sell |
51,708
-36
| -0.1% | -$2.87K | 0.77% | 24 |
|
|
2021
Q3 | $3.89M | Sell |
51,744
-1,384
| -3% | -$105K | 0.88% | 20 |
|
|
2021
Q2 | $4.13M | Sell |
53,128
-2,172
| -4% | -$162K | 0.95% | 20 |
|
|
2021
Q1 | $4.07M | Buy |
55,300
+1,320
| +2% | +$97.4K | 1.05% | 20 |
|
|
2020
Q4 | $4.21M | Buy |
53,980
+1,156
| +2% | +$88.4K | 1.2% | 17 |
|
|
2020
Q3 | $4.18M | Buy |
52,824
+28
| +0.1% | +$2.19K | 1.34% | 13 |
|
|
2020
Q2 | $3.9M | Buy |
52,796
+7,468
| +16% | +$562K | 1.38% | 15 |
|
|
2020
Q1 | $3.93M | Hold |
45,328
| – | – | 1.39% | 13 |
|
|
2019
Q4 | $3.93M | Sell |
45,328
-899
| -2% | -$73.8K | 1.38% | 13 |
|
|
2019
Q3 | $3.71M | Buy |
46,227
+742
| +2% | +$59.5K | 1.41% | 13 |
|
|
2019
Q2 | $3.64M | Sell |
45,485
-663
| -1% | -$50.8K | 1.38% | 13 |
|
|
2019
Q1 | $3.66M | Buy |
46,148
+406
| +0.9% | +$30.4K | 1.51% | 12 |
|
|
2018
Q4 | $3.33M | Buy |
45,742
+84
| +0.2% | +$5.93K | 1.55% | 12 |
|
|
2018
Q3 | $3.09M | Sell |
45,658
-125
| -0.3% | -$7.96K | 1.28% | 13 |
|
|
2018
Q2 | $2.65M | Sell |
45,783
-1,681
| -4% | -$94.8K | 1.18% | 13 |
|
|
2018
Q1 | $2.47M | Sell |
47,464
-1,356
| -3% | -$73.2K | 1.02% | 14 |
|
|
2017
Q4 | $2.62M | Buy |
48,820
+1,231
| +3% | +$68.2K | 1.03% | 14 |
|
|
2017
Q3 | $2.91M | Buy |
47,589
+2,733
| +6% | +$166K | 1.22% | 13 |
|
|
2017
Q2 | $2.74M | Buy |
44,856
+1,721
| +4% | +$105K | 1.26% | 15 |
|
|
2017
Q1 | $2.62M | Buy |
43,135
+444
| +1% | +$26.9K | 1.23% | 19 |
|
|
2016
Q4 | $2.4M | Sell |
42,691
-1,129
| -3% | -$66.1K | 1.17% | 19 |
|
|
2016
Q3 | $2.61M | Buy |
43,820
+36
| +0.1% | +$2.1K | 1.29% | 19 |
|
|
2016
Q2 | $2.41M | Buy |
43,784
+658
| +2% | +$35K | 1.23% | 18 |
|
|
2016
Q1 | $2.18M | Buy |
43,126
+22
| +0.1% | +$1.08K | 1.21% | 20 |
|
|
2015
Q4 | $2.24M | Buy |
43,104
+386
| +0.9% | +$19.5K | 1.23% | 19 |
|
|
2015
Q3 | $2.05M | Buy |
42,718
+142
| +0.3% | +$7.54K | 1.22% | 18 |
|
|
2015
Q2 | $2.31M | Buy |
42,576
+838
| +2% | +$47K | 1.39% | 15 |
|
|
2015
Q1 | $2.29M | Buy |
41,738
+152
| +0.4% | +$8.61K | 1.46% | 15 |
|
|
2014
Q4 | $2.25M | Buy |
41,586
+77
| +0.2% | +$4.29K | 1.47% | 14 |
|
|
2014
Q3 | $2.35M | Buy |
41,509
+393
| +1% | +$22.1K | 1.57% | 11 |
|
|
2014
Q2 | $2.27M | Buy |
41,116
+19
| +0% | +$1.04K | 1.65% | 12 |
|
|
2014
Q1 | $2.23M | Sell |
41,097
-1,655
| -4% | -$85.7K | 1.66% | 13 |
|
|
2013
Q4 | $2.04M | Sell |
42,752
-5,268
| -11% | -$241K | 1.53% | 14 |
|
|
2013
Q3 | $2.18M | Buy |
48,020
+10,322
| +27% | +$471K | 1.76% | 12 |
|
|
2013
Q2 | $1.67M | Buy |
+37,698
| New | +$1.68M | 1.43% | 19 |
|
Other funds holding MRK
Kistler-Tiffany Companies's MRK Position: Q2 2023 in Review
Kistler-Tiffany Companies reduced its Merck (MRK) stake by 0.31% in Q2 2023, selling an estimated $18.5K and leaving 52,875 shares worth $6.1M. The position accounts for 0.99% of the portfolio, ranked #17.
Kistler-Tiffany Companies first reported a position in MRK in Q2 2013 and has held it in 41 quarters since. 3,256 funds tracked by Wall St. Rank hold MRK as of Q2 2023.
- Kistler-Tiffany Companies held 52,875 shares of Merck worth $6.1M as of Q2 2023.
- Kistler-Tiffany Companies sold 163 Merck shares in Q2 2023, an estimated $18.5K.
- Merck made up 0.99% of Kistler-Tiffany Companies's portfolio in Q2 2023, its #17 holding.
- Kistler-Tiffany Companies first reported a position in Merck in Q2 2013 and has held it in 41 quarters since.
- 3,256 funds tracked by Wall St. Rank held Merck as of Q2 2023.
Based on Kistler-Tiffany Companies's 13F filing for Q2 2023, filed 1 Aug 2023.